Literature DB >> 6896696

Pathologic features of familial visceral myopathy.

F A Mitros, M D Schuffler, K Teja, S Anuras.   

Abstract

Familial visceral myopathy is the most common cause of chronic primary (idiopathic) intestinal pseudo-obstruction. We studied four family groups with this disease and found that it has a characteristic morphologic appearance. Grossly, there is segmental dilatation of the alimentary tract, often involving multiple sites and most commonly producing a megaduodenum. Microscopically, the involved areas show a characteristic change consisting of degenerating muscle cells and fibrosis, which may involve the full thickness of the muscularis propria but is often more prominent in or limited to the external layer. Degenerating muscle cells appear pale, poorly defined, and fragmented. As residual thread-like remnants become surrounded by collagen or as muscle cells are destroyed, leaving apparent spaces surrounded by collagen, the longitudinal and circular muscles take on a vacuolated appearance easily recognized at low magnifications. Recognition of this change is greatly facilitated by use of a trichrome stain, and mild lesions may be recognized only with such stains. The nondilated segments of intestine show similar changes but of a less severe degree. Neural and vascular structures are apparently normal. Although the lesion most closely resembles progressive systemic sclerosis, the degenerating muscle cells and vacuolated appearance of the muscle serve to distinguish familial visceral myopathy from the latter entity.

Entities:  

Mesh:

Year:  1982        PMID: 6896696     DOI: 10.1016/s0046-8177(82)80079-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Familial autonomic visceral myopathy with degeneration of muscularis mucosae.

Authors:  E M Alstead; M N Murphy; A M Flanagan; A E Bishop; H J Hodgson
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

2.  Acute on chronic intestinal pseudo-obstruction as a cause of death in a previously healthy twenty-year-old male.

Authors:  Joshua T Evans; Mark H Delegge; Christopher Lawrence; David Lewin
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

3.  Megaduodenum due to hollow visceral myopathy successfully managed by duodenoplasty and feeding jejunostomy.

Authors:  P I Mansell; R B Tattersall; M Balsitis; J Lowe; R C Spiller
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

4.  Visceral myopathy of the colon mimicking Hirschsprung's disease. Diagnosis by deep rectal biopsy.

Authors:  S H Leon; M D Schuffler
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

5.  A laparoscopic technique for full thickness intestinal biopsy and feeding jejunostomy.

Authors:  W K Eltringham; A M Roe; S W Galloway; R A Mountford; H J Espiner
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

6.  Sigmoid volvulus is associated with a decrease in enteric plexuses and ganglion cells: a case-control study.

Authors:  Keiichi Fujiya; Ja-Mun Chong; Masayuki Ando; Hidetaka Akita; Akira Fukuda; Takeshi Nagahama; Kuniyoshi Arai
Journal:  Int J Colorectal Dis       Date:  2015-02-19       Impact factor: 2.571

7.  Treatment of intestinal pseudo obstruction by segmental resection.

Authors:  A Nayci; D Avlan; A Polat; S Aksoyek
Journal:  Pediatr Surg Int       Date:  2002-12-13       Impact factor: 1.827

8.  Myofibroblasts in hollow visceral myopathy: the origin of gastrointestinal fibrosis?

Authors:  J E Martin; M Benson; M Swash; V Salih; A Gray
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

9.  Familial visceral myopathy. A family with involvement of four generations.

Authors:  S C Jones; M F Dixon; D J Lintott; A T Axon
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

10.  Visceral myopathy presenting as acute appendicitis and ogilvie syndrome.

Authors:  Punyaram Kharbuja; Raghvendra Thakur; Jian Suo
Journal:  Case Rep Surg       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.